Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Low Consultation Rate of General Population with Atrial Fibrillation.

Matsumi H, Nakamura K, Eguchi E, Miyoshi T, Nakagawa K, Nishii N, Watanabe A, Ueoka A, Yoshida M, Tokunaga N, Amioka N, Yamada N, Saito D, Morita H, Ogino K, Ito H; Ibara-AF Investigators.

Int Heart J. 2019 Nov 30;60(6):1303-1307. doi: 10.1536/ihj.19-062. Epub 2019 Nov 15.

2.

Impact of Disease Complexity on Cardiovascular Events after the Transition to an Adult Congenital Heart Disease Specialized Medical Unit.

Takahashi S, Akagi T, Toh N, Takaya Y, Nakagawa K, Nishii N, Ito H.

Acta Med Okayama. 2019 Aug;73(4):307-313. doi: 10.18926/AMO/56932.

3.

Efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with atrial septal defect: a comparison with transcatheter closure alone.

Nakagawa K, Akagi T, Nagase S, Takaya Y, Kijima Y, Toh N, Watanabe A, Nishii N, Nakamura K, Morita H, Kusano K, Ito H.

Europace. 2019 Nov 1;21(11):1663-1669. doi: 10.1093/europace/euz207.

PMID:
31410454
4.

Prognosis after lead extraction in patients with cardiac implantable electronic devices infection: Comparison of lead-related infective endocarditis with pocket infection in a Japanese single-center experience.

Nishii N, Morimoto Y, Miyoshi A, Tsukuda S, Miyamoto M, Kawada S, Nakagawa K, Watanabe A, Nakamura K, Morita H, Morimatsu H, Kusano N, Kasahara S, Shoda M, Ito H.

J Arrhythm. 2019 Jun 28;35(4):654-663. doi: 10.1002/joa3.12164. eCollection 2019 Aug.

5.

Successful radiofrequency catheter ablation of a premature ventricular contraction triggering ventricular fibrillation in a patient with short QT syndrome.

Morimoto Y, Watanabe A, Morita H, Nishii N, Nakamura K, Ito H.

HeartRhythm Case Rep. 2019 Jan 30;5(5):262-265. doi: 10.1016/j.hrcr.2019.01.012. eCollection 2019 May. No abstract available.

6.

A Low Critical Event Rate Despite a High Abnormal Event Rate in Patients with Cardiac Implantable Electric Devices Followed Up by Remote Monitoring.

Morimoto Y, Nishii N, Tsukuda S, Kawada S, Miyamoto M, Miyoshi A, Nakagawa K, Watanabe A, Nakamura K, Morita H, Ito H.

Intern Med. 2019 Aug 15;58(16):2333-2340. doi: 10.2169/internalmedicine.1905-18. Epub 2019 May 22.

7.

SMART pass will prevent inappropriate operation of S-ICD.

Tachibana M, Nishii N, Banba K, Fujita S, Ikeda E, Okawa K, Morita H, Ito H.

J Arrhythm. 2018 Nov 20;35(1):86-91. doi: 10.1002/joa3.12141. eCollection 2019 Feb.

8.

Combination of Renal Angioplasty and Angiotensin-converting-enzyme Inhibitor Can Reduce Proteinuria in Patients with Bilateral Renal Artery Disease.

Toda H, Uchida HA, Nakamura K, Takeuchi H, Kinomura M, Nakagawa K, Watanabe A, Miyoshi T, Nishii N, Morita H, Wada J, Ito H.

Intern Med. 2019 Jul 1;58(13):1917-1922. doi: 10.2169/internalmedicine.2076-18. Epub 2019 Feb 25.

9.

Percutaneous lead extraction for patients with large vegetations using an unusual technique.

Nishii N, Miyoshi A, Morimoto Y, Morita H, Kasahara S, Ito H.

HeartRhythm Case Rep. 2018 Oct 24;5(1):40-43. doi: 10.1016/j.hrcr.2018.10.008. eCollection 2019 Jan. No abstract available.

10.

A new approach for implantation of a cardiac resynchronization therapy-defibrillator in a patient with bilateral pectoral neurostimulation devices.

Tsukuda S, Nishii N, Inoue Y, Sasaki T, Morita H, Ito H.

HeartRhythm Case Rep. 2018 Jun 30;4(10):444-446. doi: 10.1016/j.hrcr.2018.06.009. eCollection 2018 Oct. No abstract available.

11.

Current Trends in Implantable Cardioverter-Defibrillator Therapy in Children - Results From the JCDTR Database.

Asakai H, Shimizu A, Mitsuhashi T, Ueyama T, Yokoshiki H, Nishii N, Sekiguchi Y, Okamura H, Morita N, Nitta T, Hirao K; Members of the Implantable Cardioverter-Defibrillator (ICD) Committee of the Japanese Heart Rhythm Society.

Circ J. 2018 Dec 25;83(1):52-55. doi: 10.1253/circj.CJ-18-0712. Epub 2018 Oct 20.

12.

Radiofrequency catheter ablation prior to percutaneous coronary intervention in patients with atrial fibrillation coexisting with stable coronary artery disease: a single-center pilot study.

Kawada S, Watanabe A, Morimoto Y, Nakagawa K, Nishii N, Nakamura K, Morita H, Ito H.

Heart Vessels. 2019 Apr;34(4):632-640. doi: 10.1007/s00380-018-1280-8. Epub 2018 Oct 15.

PMID:
30324245
13.

Progression of electrocardiographic abnormalities associated with initial ventricular fibrillation in asymptomatic patients with Brugada syndrome.

Morita H, Miyamoto M, Watanabe A, Tsukuda S, Morimoto Y, Kawada S, Nakagawa K, Nishii N, Ito H.

Heart Rhythm. 2018 Oct;15(10):1468-1474. doi: 10.1016/j.hrthm.2018.06.035. Epub 2018 Jun 25.

PMID:
29953954
14.

Shanghai Score System for Diagnosis of Brugada Syndrome: Validation of the Score System and System and Reclassification of the Patients.

Kawada S, Morita H, Antzelevitch C, Morimoto Y, Nakagawa K, Watanabe A, Nishii N, Nakamura K, Ito H.

JACC Clin Electrophysiol. 2018 Jun;4(6):724-730. doi: 10.1016/j.jacep.2018.02.009. Epub 2018 Mar 28.

15.

Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.

Ueoka A, Morita H, Watanabe A, Morimoto Y, Kawada S, Tachibana M, Miyamoto M, Nakagawa K, Nishii N, Ito H.

J Am Heart Assoc. 2018 May 10;7(10). pii: e008617. doi: 10.1161/JAHA.118.008617.

16.

Prognostic significance of nonsustained ventricular tachycardia in patients receiving cardiac resynchronization therapy for primary prevention: Analysis of the Japan cardiac device treatment registry database.

Yokoshiki H, Shimizu A, Mitsuhashi T, Furushima H, Sekiguchi Y, Manaka T, Nishii N, Ueyama T, Morita N, Okamura H, Nitta T, Hirao K, Okumura K; Members of the Implantable Cardioverter‐Defibrillator (ICD) Committee of the Japanese Heart Rhythm Society.

J Arrhythm. 2018 Jan 12;34(2):139-147. doi: 10.1002/joa3.12023. eCollection 2018 Apr.

17.

Analysis of arrhythmic events is useful to detect lead failure earlier in patients followed by remote monitoring.

Nishii N, Miyoshi A, Kubo M, Miyamoto M, Morimoto Y, Kawada S, Nakagawa K, Watanabe A, Nakamura K, Morita H, Ito H.

J Cardiovasc Electrophysiol. 2018 Mar;29(3):463-470. doi: 10.1111/jce.13399. Epub 2017 Dec 18.

PMID:
29194831
18.

Diastolic Dysfunction Is a Risk of Perioperative Myocardial Injury Assessed by High-Sensitivity Cardiac Troponin T in Elderly Patients Undergoing Non-Cardiac Surgery.

Toda H, Nakamura K, Nakagawa K, Watanabe A, Miyoshi T, Nishii N, Shimizu K, Hayashi M, Morita H, Morimatsu H, Ito H.

Circ J. 2018 Feb 23;82(3):775-782. doi: 10.1253/circj.CJ-17-0747. Epub 2017 Nov 18.

19.

Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.

Morita H, Watanabe A, Kawada S, Miyamoto M, Morimoto Y, Nakagawa K, Nishii N, Nakamura K, Ito H.

J Cardiovasc Electrophysiol. 2018 Jan;29(1):107-114. doi: 10.1111/jce.13349. Epub 2017 Oct 11.

PMID:
28940628
20.

Impact of premature activation of the right ventricle with programmed stimulation in Brugada syndrome.

Nakagawa K, Nagase S, Morita H, Wada T, Tanaka M, Murakami M, Watanabe A, Nishii N, Nakamura K, Kusano KF, Ito H, Ohe T.

J Cardiovasc Electrophysiol. 2018 Jan;29(1):71-78. doi: 10.1111/jce.13336. Epub 2017 Sep 26.

PMID:
28884873

Supplemental Content

Loading ...
Support Center